Complete Pathological Response Following Neoadjuvant FOLFIRINOX in Borderline Resectable Pancreatic Cancer - A Case Report and Review

BMC Cancer - United Kingdom
doi 10.1186/s12885-016-2821-0
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC


Related search